Infliximab induces increase in triglyceride levels in psoriatic arthritis patients

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Castro, Karla R ^a   Aikawa, Nádia E ^a   Saad, Carla Gonalves ^a   Moraes, Jlio C B ^a   Medeiros, Ana C ^a   Mota, Licia Maria H ^b   Silva, Clovis A A ^a   Bonfá, Eloísa ^a   Carvalho, Jozélio F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL UNIVERSITÁRIO DE BRASÍLIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; ETANERCEPT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INFLAMMATORY MARKER; INFLIXIMAB; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PREDNISONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPOPROTEINEMIA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MALE; POLYARTHRITIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; SPONDYLARTHRITIS; TRIACYLGLYCEROL BLOOD LEVEL; ULCEROMUTILATING ACROPATHY; BLOOD; DRUG EFFECT; LIPID METABOLISM; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; FEMALE; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; PREDNISONE; PROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 80052777107     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/352686     Document Type: Article

References (33)

1. O'Neill T., Silman A. J., Historical background and epidemiology Bailliere's Clinical Rheumatology 1994 8 2 245 261 (Pubitemid 24189838)
2. Shbeeb M., Uramoto K. M., Gibson L. E., O'Fallon W. M., Gabriel S. E., The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 19821991 Journal of Rheumatology 2000 27 5 1247 1250 (Pubitemid 30262512)
3. Leonard D. G., O'Duffy J. D., Rogers R. S., Prospective analysis of psoriatic arthritis in patients hospitalized for psoriasis Mayo Clinic Proceedings 1978 53 8 511 518 (Pubitemid 9004521)
4. Veale D., Yanni G., Rogers S., Barnes L., Bresnihan B., FitzGerald O., Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis Arthritis and Rheumatism 1993 36 7 893 900 (Pubitemid 23201103)
5. Buskila D., Langevitz P., Gladman D. D., Urowitz S., Smythe H. A., Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis Journal of Rheumatology 1992 19 7 1115 1119
6. Tsankov N. K., Kazandjieva J., Drenovska K., Drugs in exacerbation and provocation of psoriasis Clinics in Dermatology 1998 16 3 333 351 (Pubitemid 28287768)
7. Soriano E. R., McHugh N. J., Therapies for peripheral joint disease in psoriatic arthritis. A systematic review Journal of Rheumatology 2006 33 7 1422 1430 (Pubitemid 44025163)
8. Espinoza L. R., Zakraoui L., Espinoza C. G., Gutierrez F., Jara L. J., Silveira L. H., Cuellar M. L., Martinez-Osuna P., Psoriatic arthritis: clinical response and side effects to methotrexate therapy Journal of Rheumatology 1992 19 6 872 877
9. Elliott M. J., Maini R. N., Feldmann M., Long-Fox A., Charles P., Katsikis P., Brennan F. M., Walker J., Bijl H., Ghrayeb J., Woody J. N., Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor Arthritis and Rheumatism 1993 36 12 1681 1690 (Pubitemid 23360007)
10. Kavanaugh A., Krueger G. G., Beutler A., Guzzo C., Zhou B., Dooley L. T., Mease P. J., Gladman D. D., De Vlam K., Geusens P. P., Birbara C., Halter D. G., Antoni C., Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial Annals of the Rheumatic Diseases 2007 66 4 498 505 (Pubitemid 46580471)
11. Popa C., Netea M. G., Radstake T., Van der Meer J. W., Stalenhoef A. F. H., van Riel P. L., Barerra P., Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis Annals of the Rheumatic Diseases 2005 64 2 303 305 (Pubitemid 40193632)
12. Mathieu S., Dubost J. J., Tournadre A., Malochet-Guinamand S., Ristori J. M., Soubrier M., Effects of 14 weeks of TNF blockade treatment on lipid profile in ankylosing spondylitis Joint Bone Spine 2010 77 1 50 52
13. Antoniou C., Dessinioti C., Katsambas A., Stratigos A. J., Elevated triglyceride and cholesterol levels after intravenous antitumour necrosis factor- therapy in a patient with psoriatic arthritis and psoriasis vulgaris British Journal of Dermatology 2007 156 5 1090 1091 (Pubitemid 46642866)
14. Spanakis E., Sidiropoulos P., Papadakis J., Ganotakis E., Katsikas G., Karvounaris S., Bizaki A., Kritikos H., Boumpas D. T., Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab Journal of Rheumatology 2006 33 12 2440 2446 (Pubitemid 46067823)
15. Moll J. M., Wright V., Psoriatic arthritis Seminars in Arthritis and Rheumatism 1973 3 1 55 78
16. Siedel J., Hagele E. O., Ziegenhorn J., Wahlefeld A. W., Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency Clinical Chemistry 1983 29 6 1075 1080 (Pubitemid 13106884)
17. Fossati P., Prencipe L., Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide Clinical Chemistry 1982 28 10 2077 2080 (Pubitemid 12034053)
18. Warnick G. R., Cheung M. C., Albers J. J., Comparison of current methods for high-density lipoprotein cholesterol quantitation Clinical Chemistry 1979 25 4 596 604 (Pubitemid 9166999)
19. Ridker P. M., Morrow D. A., C-reactive protein, inflammation, and coronary risk Cardiology Clinics 2003 21 315 325
20. Seriolo B., Paolino S., Sulli A., Fasciolo D., Cutolo M., Effects of anti-TNF- treatment on lipid profile in patients with active rheumatoid arthritis Annals of the New York Academy of Sciences 2006 1069 414 419 (Pubitemid 43989884)
21. Soubrier M., Jouanel P., Mathieu S., Poujol D., Claus D., Dubost J. J., Ristori J. M., Effects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritis Joint Bone Spine 2008 75 1 22 24
22. Popa C., van den Hoogen F. H. J., Radstake T. R., Netea M. G., Eijsbouts A. E., Den Heijer M., Van Der Meer J. W. M., Van Riel P. L. C. M., Stalenhoef A. F. H., Barrera P., Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis Annals of the Rheumatic Diseases 2007 66 11 1503 1507 (Pubitemid 350032660)
23. Ross R., Atherosclerosisan inflammatory disease New England Journal of Medicine 1999 340 2 115 126
24. Skoog T., Dichtl W., Boquist S., Skoglund-Andersson C., Karpe F., Tang R., Bond M. G., De Faire U., Nilsson J., Eriksson P., Hamsten A., Plasma tumour necrosis factor- and early carotid atherosclerosis in healthy middle-aged men European Heart Journal 2002 23 5 376 383 (Pubitemid 35204198)
25. Popa C., Netea M. G., van Riel P. L., van der Meer J. W., Stalenhoef A. F., The role of TNF- in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk Journal of Lipid Research 2007 48 4 751 762
26. Memon R. A., Grunfeld C., Moser A. H., Feingold K. R., Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice Endocrinology 1993 132 5 2246 2253 (Pubitemid 23133278)
27. Spriggs D. R., Sherman M. L., Michie H., Arthur K. A., Imamura K., Wilmore D., Frei E., Kufe D. W., Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study Journal of the National Cancer Institute 1988 80 13 1039 1044
28. Austin M. A., Hokanson J. E., Edwards K. L., Hypertriglyceridemia as a cardiovascular risk factor American Journal of Cardiology 1998 81 4A 7B 12B (Pubitemid 28113939)
29. Jacobson T. A., Miller M., Schaefer E. J., Hypertriglyceridemia and cardiovascular risk reduction Clinical Therapeutics 2007 29 5 763 777 (Pubitemid 47232327)
30. Eder L., Zisman D., Barzilai M., Laor A., Rahat M., Rozenbaum M., Bitterman H., Feld J., Rimar D., Rosner I., Subclinical atherosclerosis in psoriatic arthritis: a case-control study Journal of Rheumatology 2008 35 5 877 882 (Pubitemid 351747131)
31. Han C., Robinson D. W. Jr., Hackett M. V., Paramore L. C., Fraeman K. H., Bala M. V., Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis Journal of Rheumatology 2006 33 11 2167 2172 (Pubitemid 44749774)
32. Gonzalez-Juanatey C., Llorca J., Amigo-Diaz E., Dierssen T., Martin J., Gonzalez-Gay M. A., High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors Arthritis and Rheumatism 2007 57 6 1074 1080 (Pubitemid 47237336)
33. Kimhi O., Caspi D., Bornstein N. M., Maharshak N., Gur A., Arbel Y., Comaneshter D., Paran D., Wigler I., Levartovsky D., Berliner S., Elkayam O., Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis Seminars in Arthritis and Rheumatism 2007 36 4 203 209 (Pubitemid 46188476)